Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells.

scientific article published on June 2016

Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/PMIC.201600002
P698PubMed publication ID27246553

P50authorThibaut LarcherQ37373430
Charles PineauQ37382984
Mélanie LagarrigueQ87896690
P2093author name stringLaurence Dubreil
Karl Rouger
Mireille Ledevin
Aurélie Lardenois
Blandine Guével
Laëtitia Guével
Sabrina Jagot
P2860cites workAnalysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturationQ24297812
Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathyQ27006945
Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell TransplantationQ27309883
Muscle-specific SIRT1 gain-of-function increases slow-twitch fibers and ameliorates pathophysiology in a mouse model of duchenne muscular dystrophyQ27314850
Fiji: an open-source platform for biological-image analysisQ27860912
Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in diseaseQ28087521
The complete sequence of the human beta-myosin heavy chain gene and a comparative analysis of its productQ28118956
Cellular and molecular regulation of muscle regenerationQ28238078
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogsQ28274324
Troponin T isoforms and posttranscriptional modifications: Evolution, regulation and functionQ28296309
Quantitative analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced proteome alterations in 5L rat hepatoma cells using isotope-coded protein labelsQ28571697
The ferritins: molecular properties, iron storage function and cellular regulationQ28609366
Murine and human myogenic cells identified by elevated aldehyde dehydrogenase activity: implications for muscle regeneration and repairQ28741359
ProteomeXchange provides globally coordinated proteomics data submission and disseminationQ29614806
Membrane organization of the dystrophin-glycoprotein complexQ29615149
Dystrophin: the protein product of the Duchenne muscular dystrophy locusQ29618077
Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouseQ30813768
The Annotation, Mapping, Expression and Network (AMEN) suite of tools for molecular systems biologyQ33318567
Human skeletal muscle-derived CD133(+) cells form functional satellite cells after intramuscular transplantation in immunodeficient host miceQ33562298
Porcine skeletal muscle-derived multipotent PW1pos/Pax7neg interstitial cells: isolation, characterization, and long-term culture.Q33690004
Haptoglobin is required to prevent oxidative stress and muscle atrophyQ33800519
Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophyQ34424160
IGF-1, inflammation and stem cells: interactions during muscle regeneration.Q34444122
Motor physical therapy affects muscle collagen type I and decreases gait speed in dystrophin-deficient dogs.Q35142741
A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber typeQ35207780
Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogsQ35475301
Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategiesQ35591025
Labile iron pool: the main determinant of cellular response to oxidative stressQ35592855
Human muscle-derived cell populations isolated by differential adhesion rates: phenotype and contribution to skeletal muscle regeneration in Mdx/SCID miceQ35706322
Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiologyQ36360412
Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse.Q36832437
Isolation of muscle-derived stem/progenitor cells based on adhesion characteristics to collagen-coated surfacesQ37065904
Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK).Q37185971
Muscular dystrophy therapy by nonautologous mesenchymal stem cells: muscle regeneration without immunosuppression and inflammationQ37352442
Canine models of Duchenne muscular dystrophy and their use in therapeutic strategiesQ37548291
Proteomic profiling of x-linked muscular dystrophyQ37676955
Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damageQ37696653
Annexin A1: novel roles in skeletal muscle biologyQ37972834
Invited review: Stem cells and muscle diseases: advances in cell therapy strategiesQ38269131
Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regenerationQ38888737
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cellsQ40243228
Training-induced morphological and functional changes in skeletal muscleQ40328007
Global/temporal gene expression in diaphragm and hindlimb muscles of dystrophin-deficient (mdx) miceQ40639635
Muscle genome-wide expression profiling during disease evolution in mdx mice.Q44471658
Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy.Q45966003
Apolipoprotein E-/- mice have delayed skeletal muscle healing after hind limb ischemia-reperfusionQ46524635
Cytoplasmic gelsolin in pheochromocytoma-12 cells forms a complex with amyloid beta-proteinQ46743519
Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophyQ47314000
Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) miceQ47745483
Gene expression profiling of Duchenne muscular dystrophy skeletal muscleQ47970351
Quantitative proteomic Isotope-Coded Protein Label (ICPL) analysis reveals alteration of several functional processes in the glioblastomaQ48520367
Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies.Q50892927
Quantitative proteomic analysis of dystrophic dog muscle.Q54382935
Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progressionQ57588305
The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogsQ59051983
P433issue14
P304page(s)2028-2042
P577publication date2016-07-01
P1433published inProteomicsQ15614164
P1476titleQuantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells
P478volume16

Reverse relations

cites work (P2860)
Q92996733Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
Q93241613Genetic suppression of cryoprotectant toxicity
Q97646321Human MuStem Cell Grafting into Infarcted Rat Heart Attenuates Adverse Tissue Remodeling and Preserves Cardiac Function
Q52714547Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches.
Q47959546Proteomic profiling of the dystrophin complex and membrane fraction from dystrophic mdx muscle reveals decreases in the cytolinker desmoglein and increases in the extracellular matrix stabilizers biglycan and fibronectin.
Q46245053Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle.